Wernicke's Encephalopathy

Table of Contents

1. Why Thiamine Is Essential for the Brain
2. Which Brain Regions Are Affected and Why
3. Causes: Alcoholic and Non-Alcoholic
4. The Classic Triad — and Why It Misses Most Cases
5. Diagnosis: Magnetic Resonance Imaging, Blood Tests, and Clinical Judgment
6. Treatment: Intravenous Thiamine Without Delay
7. If Untreated: Progression to Korsakoff Syndrome
8. Prevention and Thiamine Prophylaxis
9. Key Research Papers
10. Connections
11. Featured Videos

Why Thiamine Is Essential for the Brain

Thiamine pyrophosphate (TPP) is the active cofactor for three essential mitochondrial enzymes that sit at the heart of cellular energy metabolism:

1. Pyruvate dehydrogenase (PDH): converts pyruvate to acetyl-CoA, the entry point into the tricarboxylic acid (TCA) cycle. Without this step, glucose-derived energy cannot enter aerobic oxidation.
2. Alpha-ketoglutarate dehydrogenase (KGDH): catalyzes a key TCA cycle step, converting alpha-ketoglutarate to succinyl-CoA and generating reduced nicotinamide adenine dinucleotide for the electron transport chain.
3. Transketolase: drives the pentose phosphate pathway, producing ribose-5-phosphate for nucleotide synthesis and reduced nicotinamide adenine dinucleotide phosphate (NADPH) for antioxidant defense.

When thiamine is absent, glucose cannot be metabolized through aerobic pathways. Neurons are forced into anaerobic glycolysis, generating lactic acid and yielding only a fraction of normal adenosine triphosphate (ATP). The brain is entirely glucose-dependent — it cannot switch to fatty acids as an energy substrate. Neurons in brain regions with the highest metabolic demand are therefore hit first and hardest.

The body stores only 18–30 mg of thiamine in total, with a metabolic half-life of approximately 18 days. Clinical deficiency can develop within 3–4 weeks of inadequate intake or impaired absorption. The daily requirement is 1.1–1.2 mg in healthy adults, but heavily alcohol-dependent individuals often consume less than 0.5 mg per day and simultaneously have impaired intestinal absorption, creating a rapid dual depletion.

Which Brain Regions Are Affected and Why

Not all brain regions are equally vulnerable. Wernicke's Encephalopathy produces selective, anatomically predictable damage because certain structures combine extremely high metabolic demand with relatively low thiamine turnover and poor vascularization. The key affected regions are:

• Mamillary bodies: the pathognomonic lesion of Wernicke's. These paired structures relay memory circuits in the Papez loop (hippocampus → fornix → mamillary bodies → anterior thalamus → cingulate cortex → hippocampus). They are tiny, poorly vascularized, and metabolically intense — the first structures to fail.
• Dorsomedial thalamus: damage here, paired with mamillary body injury, produces the dense amnesia of Korsakoff Syndrome.
• Periaqueductal gray (PAG): a midbrain region governing eye movements, consciousness, and autonomic tone. PAG damage explains altered consciousness and oculomotor dysfunction.
• Oculomotor nuclei (cranial nerves III and VI): direct involvement explains nystagmus, lateral rectus palsy, and conjugate gaze palsies.
• Cerebellar vermis: controls truncal and gait coordination; vermis damage produces the characteristic ataxia of Wernicke's.
• Cerebral cortex: relatively spared acutely, which is why intellectual function is often preserved in isolated Wernicke's Encephalopathy.

The underlying mechanism combines multiple injurious processes: adenosine triphosphate depletion → oxidative stress (excess reactive oxygen species from impaired reduced nicotinamide adenine dinucleotide phosphate production) → glutamate excitotoxicity (energy failure impairs glutamate reuptake) → lactic acidosis → blood-brain barrier breakdown → selective neuronal death. The result is focal vasogenic and cytotoxic edema visible on magnetic resonance imaging (MRI), followed by neuronal loss and gliosis if thiamine is not restored promptly.

Causes: Alcoholic and Non-Alcoholic

Alcoholic Wernicke's Encephalopathy is the most recognized form in Western countries, accounting for roughly 50–80% of cases in published series. Chronic heavy alcohol use depletes thiamine through four overlapping mechanisms: poor dietary intake and anorexia; impaired intestinal absorption (alcohol directly damages the active thiamine transport system in the duodenum); accelerated thiamine metabolism; and impaired hepatic phosphorylation of thiamine to its active TPP form. It is critical to understand that the diagnosis of Wernicke's Encephalopathy is not synonymous with alcoholism — alcohol use disorder is a common risk context, not the disease itself.

Non-alcoholic Wernicke's Encephalopathy is increasingly recognized and may account for 20–40% of cases. Causes include:

• Gastric bypass and bariatric surgery: the leading non-alcoholic cause. Reduced gastric acid production and rapid small-intestinal transit impair thiamine absorption; onset typically 4–12 weeks post-operatively. The 2010 European Federation of Neurological Societies (EFNS) guideline recommends follow-up of thiamine status for at least 6 months after bariatric surgery, and parenteral thiamine supplementation.
• Hyperemesis gravidarum: prolonged vomiting in early pregnancy depletes thiamine within 3–4 weeks. Vomiting in pregnancy that lasts more than two weeks is a setting in which parenteral (injected) thiamine is given to prevent Wernicke's Encephalopathy.
• Prolonged nothing-by-mouth (NPO) status or total parenteral nutrition (TPN) without thiamine supplementation: a preventable hospital-caused (iatrogenic) cause in hospitalized patients; cases arise when intravenous feeding runs without thiamine.
• Refeeding syndrome: rapid carbohydrate loading in a severely malnourished patient consumes the remaining trace thiamine stores as glycolysis accelerates, precipitating acute Wernicke's Encephalopathy.
• Malignancy: particularly gastrointestinal cancers, which combine anorexia, malabsorption, and increased metabolic demand for thiamine.
• Acquired immunodeficiency syndrome (AIDS) and human immunodeficiency virus-related illness: malabsorption, chronic diarrhea, poor intake, and opportunistic gastrointestinal (GI) infections all impair thiamine status.
• Renal dialysis: thiamine is water-soluble and is removed during hemodialysis sessions, so dialysis patients lose thiamine at every session.
• Anorexia nervosa and severe dietary restriction: particularly high-risk in adolescent girls and young women with prolonged caloric restriction.
• Prolonged starvation: including in refugee populations and extreme fasting practices.

A 2015 systematic review of 623 published cases of Wernicke-Korsakoff syndrome in people without alcohol use disorder (reports from 1867 to 2014) found that these patients were more often women and younger, had a shorter precipitating illness and a better survival rate than people with alcohol-related disease. The most common sign was an altered mental state. Korsakoff syndrome or ongoing memory problems were reported in 25% of these cases, although many reports did not state the person's memory status.

The Classic Triad — and Why It Misses Most Cases

Medical education historically taught Wernicke's Encephalopathy as a triad: oculomotor dysfunction, cerebellar ataxia, and confusion. In practice, all three components are present simultaneously in only 10–16% of patients in large clinical series. When only the full triad is accepted as the diagnosis, most cases are missed.

Each component of the triad:

1. Oculomotor dysfunction: horizontal nystagmus is the most common finding (present in roughly 80–90% of cases at autopsy-confirmed WE). Lateral rectus palsy (abducens nerve, cranial nerve VI) produces diplopia and impaired abduction. Conjugate gaze palsies occur in severe cases. These signs reflect damage to the periaqueductal gray and oculomotor nuclei.
2. Cerebellar ataxia: predominantly gait ataxia and truncal instability from cerebellar vermis damage. Limb coordination (finger-to-nose, heel-to-shin) is often relatively preserved. The patient may appear simply "unsteady" or "drunk" — easy to attribute to intoxication in a patient with alcohol use disorder.
3. Altered consciousness / confusion: presents most commonly as apathy, disorientation, and attentional impairment. Frank stupor or coma indicates severe or advanced disease. Mild cognitive slowing or "seeming a bit off" is often overlooked or attributed to intoxication or other causes.

The revised Caine criteria improve sensitivity dramatically by requiring only 2 of 4 features: (1) dietary deficiency, (2) oculomotor abnormality, (3) cerebellar ataxia, or (4) either mild cognitive impairment or altered consciousness. Caine and colleagues (1997) built these criteria from the records of 28 people with alcohol use disorder whose diagnosis was confirmed at autopsy, then tested them on 106 people with alcohol use disorder drawn from a large autopsy sample. Three independent raters classified the records the same way every time, and the criteria missed Wernicke's Encephalopathy mainly when it occurred together with liver-related brain dysfunction (hepatic encephalopathy), where sensitivity was 50%. The 2010 EFNS guideline adopted the same two-of-four rule for diagnosis in people with alcohol use disorder.

In practice: the absence of the full classic triad does not exclude Wernicke's Encephalopathy. The EFNS guideline states that thiamine is indicated for suspected as well as confirmed disease, that the condition is to be suspected in every setting that can lead to thiamine deficiency, and that the overall safety of thiamine is very good. At-risk groups include people with alcohol use disorder, bariatric surgery, hyperemesis, prolonged nothing-by-mouth status, cancer, acquired immunodeficiency syndrome, or dialysis. Treatment is not held back for magnetic resonance imaging results, because the cost of delay is irreversible brain damage.

Diagnosis: Magnetic Resonance Imaging, Blood Tests, and Clinical Judgment

Wernicke's Encephalopathy is ultimately a clinical diagnosis. Investigations support and confirm it; in a clinically suspicious case they are not a reason to delay treatment.

Magnetic resonance imaging brain (FLAIR + DWI sequences) is the most useful imaging modality:

• Classic finding: symmetric T2/FLAIR hyperintensity (edema and metabolic injury) in the mamillary bodies (pathognomonic when present), periaqueductal gray, and medial thalami.
• Sensitivity of magnetic resonance imaging in acute Wernicke's Encephalopathy is approximately 53% — a negative magnetic resonance imaging does not exclude the diagnosis.
• DWI sequences may show restricted diffusion (cytotoxic edema) in acute disease.
• Follow-up magnetic resonance imaging weeks to months later characteristically shows mamillary body atrophy — a scar of prior Wernicke's — even after clinical recovery.

Blood thiamine (thiamine pyrophosphate, TPP):

• Whole-blood TPP is the most accurate assay. The EFNS guideline states that total thiamine in a blood sample is measured immediately before thiamine is given, and the sample is taken before intravenous (IV) glucose.
• A low result confirms thiamine deficiency. A normal result does not exclude Wernicke's Encephalopathy — tissue stores (particularly in the brain) may already be critically depleted while blood levels remain borderline.
• Glucose and thiamine: intravenous glucose administered to a thiamine-depleted patient accelerates glycolysis, consuming the last remaining TPP in neurons and can precipitate or dramatically worsen acute Wernicke's Encephalopathy. The EFNS guideline states that thiamine is given before any carbohydrate.

Additional investigations in the assessment of a suspected Wernicke's Encephalopathy patient commonly include: blood glucose, electrolytes, magnesium (low magnesium, hypomagnesemia, impairs thiamine utilization), complete blood count (CBC), liver function tests, and vitamin B12. These help exclude mimics and identify contributing metabolic abnormalities.

Treatment: Intravenous Thiamine Without Delay

The central point: the EFNS guideline states that thiamine is given before any carbohydrate, and that parenteral thiamine is given to all at-risk people admitted to the emergency room. This applies in every clinical setting — emergency department, ward, intensive care unit (ICU). Oral thiamine is not considered adequate treatment for acute Wernicke's Encephalopathy because intestinal absorption is unreliable in the very patient populations at highest risk (malnourished, alcoholic, post-bariatric).

Dosing:

• EFNS guideline (2010): for suspected or manifest Wernicke's Encephalopathy, thiamine 200 mg three times daily, given before any carbohydrate, preferably intravenously (graded Level C in the guideline).
• No single agreed dose: a 2014 Australian review noted that there are no universally accepted guidelines on the best dose, route, frequency or length of thiamine treatment, and that different dose recommendations are being made.
• The first dose trials (2022): two randomized, double-blind trials in Australia compared injected thiamine doses in people with alcohol misuse. For prevention, 393 people without symptoms received 100 mg once daily, 100 mg three times daily, or 300 mg three times daily for 3 days. For treatment, 127 people with symptoms received 100 mg, 300 mg or 500 mg three times daily for 5 days. Neither trial found a significant difference between doses in thinking (cognition) or in balance, eye movements and confusion at follow-up. The authors noted several limits of the trials, and that magnesium and other B-vitamin deficiencies are considered and corrected.
• The intravenous route is preferred over intramuscular (IM) injection because absorption is faster and tissue levels are more reliably achieved.

Expected response to treatment:

• Oculomotor abnormalities: often begin improving within hours to 1–2 days — the fastest and most reassuring sign of treatment response.
• Gait ataxia: improves over days to weeks; may not fully resolve.
• Confusion and altered consciousness: typically recover over days to weeks.
• Memory: may not recover if Korsakoff Syndrome has already developed (see below).

Magnesium correction is an important adjunct: magnesium is required for TPP synthesis and utilization. Low magnesium impairs the response to thiamine supplementation, and it is corrected at the same time.

Anaphylaxis risk from intravenous thiamine is extremely rare — estimated at fewer than 1 in 100,000 doses. This risk is small compared with the certainty of irreversible brain damage from untreated Wernicke's Encephalopathy, and the EFNS guideline rates the overall safety of thiamine as very good.

If Untreated: Progression to Korsakoff Syndrome

Approximately 80% of patients with untreated or inadequately treated Wernicke's Encephalopathy develop Korsakoff Syndrome — a permanent amnestic disorder resulting from irreversible thalamo-mamillary neuronal death. The Wernicke-Korsakoff Syndrome is best understood as a clinical spectrum: Wernicke's Encephalopathy is the acute, potentially reversible phase; Korsakoff Syndrome is the chronic, largely irreversible sequela.

Key features of Korsakoff Syndrome:

• Severe anterograde amnesia: profound inability to form new long-term memories. The patient cannot learn new information that persists for more than minutes.
• Retrograde amnesia: loss of memories from months to years before the illness, typically with a temporal gradient (older memories better preserved than recent ones).
• Confabulation: the patient fills memory gaps with fabricated but plausible-sounding information, typically without awareness of doing so. This is not deliberate lying — it reflects the brain's attempt to construct coherent narrative from fragmentary or absent memory traces.
• Preserved immediate memory: the patient can repeat a phone number immediately after hearing it — the defect is in consolidation (transfer to long-term memory), not in immediate registration.
• Preserved intellectual function: language, reasoning, and procedural skills are relatively intact. This makes the amnesia all the more striking and disabling.

Prognosis of established Korsakoff Syndrome even with adequate thiamine is sobering:

• 25% achieve full recovery of memory function.
• 50% achieve partial improvement.
• 25% have no meaningful improvement and require permanent institutional care.

Because established Korsakoff Syndrome recovers poorly, prevention matters most. A 2014 review describes urgent and adequate thiamine replacement as necessary to avoid death or progression to Korsakoff Syndrome.

Prevention and Thiamine Prophylaxis

Parenteral thiamine is given prophylactically — without waiting for symptoms — in the following clinical settings described in guidelines and reviews (the EFNS guideline lists all at-risk people admitted to the emergency room):

• Alcohol use disorder presenting with any acute illness, injury, or surgery. These patients are often thiamine-depleted at baseline and any metabolic stress can precipitate acute Wernicke's.
• Malnourished patients before intravenous glucose or TPN infusions. Any carbohydrate load in a thiamine-depleted patient risks triggering refeeding-related WE.
• Bariatric surgery: the EFNS guideline recommends follow-up of thiamine status for at least 6 months after surgery and parenteral thiamine supplementation. Deficiency can develop within weeks of surgery.
• Hyperemesis gravidarum lasting more than two weeks: pregnant women who cannot keep up oral nutrition for this long are a group given parenteral thiamine.
• Any prolonged nothing-by-mouth status or TPN: hospital-acquired Wernicke's Encephalopathy from thiamine-deficient TPN is entirely preventable when thiamine is included in the feeding.
• Renal dialysis patients: regular thiamine supplementation replaces what is removed each session.

Oral versus parenteral prophylaxis: in patients with normal gut function and no malabsorption, high-dose oral thiamine (100–300 mg/day) is described as adequate for maintenance. In patients with active alcohol use disorder, malabsorption, or recent surgery, parenteral routes are used because intestinal absorption is too unreliable.

Dietary thiamine sources include fortified cereals, pork, legumes, sunflower seeds, and whole grains. However, dietary sources alone are described as insufficient in the high-risk patient populations above, which is why supplementation is used regardless of dietary thiamine content.

The UK National Health Service uses an intravenous high-dose B-vitamin preparation containing thiamine (together with riboflavin, pyridoxine, nicotinamide, and ascorbic acid) widely in alcohol-related hospital admissions as standard prophylaxis. This approach has substantially reduced hospital-acquired Wernicke's Encephalopathy in settings where it is consistently implemented.

Key Research Papers

1. Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA; EFNS. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408–18. — doi:10.1111/j.1468-1331.2010.03153.x · PubMed PMID: 20642790 — The European guideline: thiamine 200 mg three times daily, preferably intravenously, before any carbohydrate (Level C); the two-of-four diagnostic signs in alcohol use disorder; thiamine follow-up for at least 6 months after bariatric surgery; parenteral thiamine for all at-risk emergency-room admissions.
2. Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51–60. — doi:10.1136/jnnp.62.1.51 · PubMed PMID: 9010400 — Established the revised diagnostic criteria (2 of 4 features), built from 28 autopsy-confirmed cases and tested on 106 people from an autopsy sample.
3. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442–55. — doi:10.1016/S1474-4422(07)70104-7 · PubMed PMID: 17434099 — Landmark review documenting the full spectrum of non-alcoholic WE causes and updating diagnostic and management approaches.
4. Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010;25(4):576–81. — doi:10.1016/j.jcrc.2010.03.003 · PubMed PMID: 20646908 — Observational study (no treatment given) of 30 people with sepsis: 3 (10%) were thiamine-deficient on arrival and 6 (20%) within 72 hours; none of 30 controls.
5. Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014;44(9):911–5. — doi:10.1111/imj.12522 · PubMed PMID: 25201422 — Practical clinical review of thiamine dosing, route selection, and evidence base for parenteral over oral administration in alcohol-use-disorder patients.
6. Yu AT, Gross A, Park K, Harvey EJ. Wernicke encephalopathy after bariatric surgery: a literature review. Obes Surg. 2023;33(11):3621–7. — doi:10.1007/s11695-023-06840-8 · PubMed PMID: 37798508 — Case series and review highlighting bariatric surgery as the leading non-alcoholic cause of WE and the need for lifelong thiamine supplementation post-operatively.
7. Chiossi G, et al. Hyperemesis gravidarum complicated by Wernicke encephalopathy: background, case report, and review of the literature. Obstet Gynecol Surv. 2006;61(4):255–68. — doi:10.1097/01.ogx.0000206336.08794.65 · PubMed PMID: 16551377 — Documents WE complicating pregnancy-related vomiting and establishes thiamine replacement as mandatory in prolonged hyperemesis gravidarum.
8. Kopelman MD. The Korsakoff syndrome. Br J Psychiatry. 1995;166(2):154–73. — doi:10.1192/bjp.166.2.154 · PubMed PMID: 7728359 — Comprehensive review of the neuropsychology of Korsakoff Syndrome, covering amnesia types, confabulation, and the neuroanatomical basis of thalamo-mamillary damage.
9. Pitel AL, Beaunieux H, Witkowski T, Vabret F, Guillery-Girard B, Quinette P, Desgranges B, Eustache F. Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence. Alcohol Clin Exp Res. 2007;31(7):1169–78. — doi:10.1111/j.1530-0277.2007.00418.x · PubMed PMID: 17511749 — Neuropsychological study of 40 recently detoxified inpatients and 55 controls: genuine episodic memory deficits early in abstinence that cannot be regarded solely as the result of executive dysfunction.
10. Dingwall KM, Delima JF, Binks P, Batey R, Bowden SC. What is the optimum thiamine dose to treat or prevent Wernicke's encephalopathy or Wernicke-Korsakoff syndrome? Results of a randomized controlled trial. Alcohol Clin Exp Res. 2022;46(6):1133–1147. — doi:10.1111/acer.14843 · PubMed PMID: 35428992 — Two randomized trials (393 at-risk and 127 symptomatic patients; 100 mg once daily up to 500 mg three times daily): no clear benefit of high-dose over intermediate or lower doses.
11. Scalzo SJ, Bowden SC, Ambrose ML, Whelan G, Cook MJ. Wernicke-Korsakoff syndrome not related to alcohol use: a systematic review. J Neurol Neurosurg Psychiatry. 2015;86(12):1362–8. — doi:10.1136/jnnp-2014-309598 · PubMed PMID: 25589780 — Systematic review of 623 published cases not related to alcohol: more often women and younger, with better survival than alcohol-related cases; Korsakoff syndrome or ongoing memory impairment reported in 25%.

Back to Table of Contents

Connections

• Neurology
• What Alcohol Does Inside Your Liver — interactive animation
• Korsakoff Syndrome
• Alcohol Use Disorder
• Thiamine (Vitamin B1)
• Peripheral Neuropathy
• Malabsorption Syndrome
• Subacute Combined Degeneration
• Wernicke-Korsakoff Syndrome — the combined entity, spanning this acute phase and the chronic Korsakoff amnesia that can follow it.

Back to Table of Contents

Featured Videos